1,620
Views
25
CrossRef citations to date
0
Altmetric
Research Article

In vitro study of AFB1 and AFM1 effects on human lymphoblastoid Jurkat T-cell model

, , , , &
Pages 353-358 | Received 18 Jun 2013, Accepted 20 Sep 2013, Published online: 22 Oct 2013

Figures & data

Table 1. Primer sequences.

Figure 1. Effects of AFB1 and AFM1 on Jurkat cell proliferation. Jurkat T-cells were incubated in the presence of increasing concentrations (3–50 μM) of AFB1 (black bar) or AFM1 (grey bar) for 24 h. Eighteen hours prior to harvesting, cells were pulsed with 1 µCi/well [3H]-thymidine. DNA synthesis was then measured by [3H]-thymidine incorporation and expressed as counts per minute (cpm). Control (ctr): cells incubated with medium containing ethanol (0.1%) only. Each value represents the mean ± SD of three independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001 versus ctr.

Figure 1. Effects of AFB1 and AFM1 on Jurkat cell proliferation. Jurkat T-cells were incubated in the presence of increasing concentrations (3–50 μM) of AFB1 (black bar) or AFM1 (grey bar) for 24 h. Eighteen hours prior to harvesting, cells were pulsed with 1 µCi/well [3H]-thymidine. DNA synthesis was then measured by [3H]-thymidine incorporation and expressed as counts per minute (cpm). Control (ctr): cells incubated with medium containing ethanol (0.1%) only. Each value represents the mean ± SD of three independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001 versus ctr.

Figure 2. Effects of AFB1 and AFM1 on Jurkat cell caspase-3 activity and LDH release. (a) Each end-point was analyzed following exposure to AFB1 (black bar) or AFM1 (grey bar) for 24 h. Control (ctr) cells were incubated with medium containing ethanol (0.1%) only. In (a), cells treated with 10 μM actinomycin D (ActD) served as positive control. Values were ultimately expressed as nmole AMC/mg protein in cell lysate. In (b), cells treated with 1% NP-40 served as positive control. Amount of LDH released into medium was expressed as a percentage of LDH released from positive control. All values represent mean ± SD of three independent experiments. ***p < 0.001 versus ctr.

Figure 2. Effects of AFB1 and AFM1 on Jurkat cell caspase-3 activity and LDH release. (a) Each end-point was analyzed following exposure to AFB1 (black bar) or AFM1 (grey bar) for 24 h. Control (ctr) cells were incubated with medium containing ethanol (0.1%) only. In (a), cells treated with 10 μM actinomycin D (ActD) served as positive control. Values were ultimately expressed as nmole AMC/mg protein in cell lysate. In (b), cells treated with 1% NP-40 served as positive control. Amount of LDH released into medium was expressed as a percentage of LDH released from positive control. All values represent mean ± SD of three independent experiments. ***p < 0.001 versus ctr.

Figure 3. Effects of AFB1 and AFM1 on the Jurkat T cell cytokine expression. mRNA levels of select cytokines in Jurkat cells following 24-h incubation with PMA/ionomycin concurrent with increasing concentrations (3–50 μM) of AFB1 (black bar) or AFM1 (grey bar). Control (ctr) was unstimulated cells; the positive control (ctr+) was cells incubated with PMA/ionomycin. Unstimulated cells were incubated with medium containing ethanol (0.1%) only. mRNA levels of (a) IFNγ, (b) IL-2, (c) IL-8, and L-32 were subsequently assessed by real-time PCR analysis. Results represent mean ± SD of two independent experiments. ***p < 0.001 versus ctr+.

Figure 3. Effects of AFB1 and AFM1 on the Jurkat T cell cytokine expression. mRNA levels of select cytokines in Jurkat cells following 24-h incubation with PMA/ionomycin concurrent with increasing concentrations (3–50 μM) of AFB1 (black bar) or AFM1 (grey bar). Control (ctr) was unstimulated cells; the positive control (ctr+) was cells incubated with PMA/ionomycin. Unstimulated cells were incubated with medium containing ethanol (0.1%) only. mRNA levels of (a) IFNγ, (b) IL-2, (c) IL-8, and L-32 were subsequently assessed by real-time PCR analysis. Results represent mean ± SD of two independent experiments. ***p < 0.001 versus ctr+.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.